NON-SMALL CELL LUNG CARCINOMA
Clinical trials for NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to reboot immune attack in resistant cancers
Disease control Recruiting nowThis early-phase trial tests a combination of two drugs—retifanlimab (an immunotherapy) and ruxolitinib (a targeted pill)—in people with advanced lung or kidney cancer whose disease worsened after standard immunotherapy. The main goal is to find the safest dose of ruxolitinib whe…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New hope for tough lung cancers: experimental drug takes on standard chemo
Disease control Recruiting nowThis study tests a new drug, PF-08046054, against the standard chemo docetaxel for people with advanced PD-L1 positive non-small cell lung cancer that has spread or can't be removed. About 680 adults whose cancer got worse after prior treatments will be randomly assigned to one o…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC